Steven Yatomi-Clarke
Algemeen Directeur bij PRESCIENT THERAPEUTICS LIMITED
Vermogen: 378 056 $ op 30-04-2024
Profiel
Steven Yatomi-Clarke is currently the Chief Executive Officer, MD & Executive Director at Prescient Therapeutics Ltd.
He started this position in 2016.
Previously, he worked as the Director-Corporate Finance at Patersons Securities Ltd.
He has an undergraduate degree from the University of Melbourne.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
01-05-2023 | 11 195 017 ( 1.39% ) | 378 056 $ | 30-04-2024 |
Actieve functies van Steven Yatomi-Clarke
Bedrijven | Functie | Begin |
---|---|---|
PRESCIENT THERAPEUTICS LIMITED | Algemeen Directeur | 15-02-2016 |
Eerdere bekende functies van Steven Yatomi-Clarke
Bedrijven | Functie | Einde |
---|---|---|
Patersons Securities Ltd.
Patersons Securities Ltd. Investment Banks/BrokersFinance Patersons Securities Ltd. is a brokerage firm that provides brokerage services. The company was founded in 1903 and is based in Perth, Australia. Patersons Securities was acquired by Canaccord Genuity (Australia) Ltd. on October 21, 2019 for $17.42 million. | Corporate Officer/Principal | - |
Opleiding van Steven Yatomi-Clarke
University of Melbourne | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
PRESCIENT THERAPEUTICS LIMITED | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Patersons Securities Ltd.
Patersons Securities Ltd. Investment Banks/BrokersFinance Patersons Securities Ltd. is a brokerage firm that provides brokerage services. The company was founded in 1903 and is based in Perth, Australia. Patersons Securities was acquired by Canaccord Genuity (Australia) Ltd. on October 21, 2019 for $17.42 million. | Finance |